全文获取类型
收费全文 | 51386篇 |
免费 | 4819篇 |
国内免费 | 1474篇 |
专业分类
耳鼻咽喉 | 470篇 |
儿科学 | 1289篇 |
妇产科学 | 627篇 |
基础医学 | 3312篇 |
口腔科学 | 1768篇 |
临床医学 | 10777篇 |
内科学 | 8072篇 |
皮肤病学 | 1296篇 |
神经病学 | 1903篇 |
特种医学 | 1958篇 |
外国民族医学 | 1篇 |
外科学 | 3914篇 |
综合类 | 7896篇 |
现状与发展 | 12篇 |
一般理论 | 8篇 |
预防医学 | 7441篇 |
眼科学 | 1046篇 |
药学 | 3260篇 |
79篇 | |
中国医学 | 1935篇 |
肿瘤学 | 615篇 |
出版年
2024年 | 52篇 |
2023年 | 1171篇 |
2022年 | 1534篇 |
2021年 | 2548篇 |
2020年 | 2792篇 |
2019年 | 2144篇 |
2018年 | 1947篇 |
2017年 | 1883篇 |
2016年 | 2115篇 |
2015年 | 1880篇 |
2014年 | 3526篇 |
2013年 | 3992篇 |
2012年 | 3140篇 |
2011年 | 3279篇 |
2010年 | 2759篇 |
2009年 | 2634篇 |
2008年 | 2442篇 |
2007年 | 2476篇 |
2006年 | 2165篇 |
2005年 | 1922篇 |
2004年 | 1546篇 |
2003年 | 1383篇 |
2002年 | 1076篇 |
2001年 | 1059篇 |
2000年 | 870篇 |
1999年 | 696篇 |
1998年 | 610篇 |
1997年 | 521篇 |
1996年 | 385篇 |
1995年 | 509篇 |
1994年 | 392篇 |
1993年 | 230篇 |
1992年 | 245篇 |
1991年 | 227篇 |
1990年 | 180篇 |
1989年 | 189篇 |
1988年 | 164篇 |
1987年 | 156篇 |
1986年 | 124篇 |
1985年 | 145篇 |
1984年 | 116篇 |
1983年 | 68篇 |
1982年 | 76篇 |
1981年 | 45篇 |
1980年 | 71篇 |
1979年 | 38篇 |
1978年 | 30篇 |
1977年 | 32篇 |
1976年 | 29篇 |
1975年 | 19篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
32.
Bacterial keratitis continues to be one of the leading causes of corneal blindness in the developed as well as the developing world, despite swift progress since the dawn of the “anti-biotic era”. Although, we have expeditiously developed our understanding about the different causative organisms and associated pathology leading to keratitis, extensive gaps in knowledge continue to dampen the efforts required for early and accurate diagnosis, and management in these patients, resulting in poor clinical outcomes. The ability of the causative bacteria to subdue the therapeutic challenge stems from their large genome encoding complex regulatory networks, variety of unique virulence factors, and rapid secretion of tissue damaging proteases and toxins.In this review article, we provide an overview of the established diagnostic techniques and therapeutics for keratitis caused by various bacteria. We extensively report the recent in-roads through novel tools for accurately diagnosing mono- and poly-bacterial corneal infections. Furthermore, we outline the recent progress by our groups and others in understanding the sub-cellular genomic changes that lead to antibiotic resistance in these organisms. Finally, we discuss in detail, the novel therapies and drug delivery systems in development for the efficacious management of bacterial keratitis. 相似文献
33.
34.
Susan Thurstans Natalie Sessions Carmel Dolan Kate Sadler Bernardette Cichon Sheila Isanaka Dominique Roberfroid Heather Stobaugh Patrick Webb Tanya Khara 《Maternal & child nutrition》2022,18(1):e13246
In 2014, the Emergency Nutrition Network published a report on the relationship between wasting and stunting. We aim to review evidence generated since that review to better understand the implications for improving child nutrition, health and survival. We conducted a systematic review following PRISMA guidelines, registered with PROSPERO. We identified search terms that describe wasting and stunting and the relationship between the two. We included studies related to children under five from low- and middle-income countries that assessed both ponderal growth/wasting and linear growth/stunting and the association between the two. We included 45 studies. The review found the peak incidence of both wasting and stunting is between birth and 3 months. There is a strong association between the two conditions whereby episodes of wasting contribute to stunting and, to a lesser extent, stunting leads to wasting. Children with multiple anthropometric deficits, including concurrent stunting and wasting, have the highest risk of near-term mortality when compared with children with any one deficit alone. Furthermore, evidence suggests that the use of mid-upper-arm circumference combined with weight-for-age Z score might effectively identify children at most risk of near-term mortality. Wasting and stunting, driven by common factors, frequently occur in the same child, either simultaneously or at different moments through their life course. Evidence of a process of accumulation of nutritional deficits and increased risk of mortality over a child's life demonstrates the pressing need for integrated policy, financing and programmatic approaches to the prevention and treatment of child malnutrition. 相似文献
35.
36.
长期以来的研究表明先天免疫和后天免疫在宿主抵御外来微生物入侵的过程中起着至关重要的作用,而在这过程中也会同时造成宿主自身的组织或器官的损害。骨骼系统就是其中之一,在一些诸如类风湿性关节炎、牙周炎等疾病中,免疫系统的反应不仅起到去除外来致病菌的作用,还会同时造成骨骼系统的破坏。长期以来大部分的研究都致力于了解免疫系统对骨组织破坏的机制,而近些年来有研究开始探究骨反作用于免疫系统,由此衍生出了一个全新的研究领域——骨免疫。文章从骨免疫的机制、免疫与骨吸收作用通路以及在口腔相关疾病的作用机制等方面总结了近些年来相关的研究进展。 相似文献
38.
Conan MacDougall Theora Canonica Chris Keh Binh An P. Phan Janice Louie 《Pharmacotherapy》2022,42(4):343-361
Rifamycins (rifampin, rifabutin, and rifapentine) play an essential role in the treatment of mycobacterial and some nonmycobacterial infections. They also induce the activity of various drug transporting and metabolizing enzymes, which can impact the concentrations and efficacy of substrates. Many anticoagulant and antiplatelet (AC/AP) agents are substrates of these enzymes and have narrow therapeutic indices, leading to risks of thrombosis or bleeding when coadministered with rifamycins. The objective of this systematic review was to evaluate the effects on AC/AP pharmacokinetics, laboratory markers, and clinical safety and efficacy of combined use with rifamycins. A systematic review following the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidance was performed. The PubMed, Embase, and Web of Science databases were queried for English-language reports on combination use of rifamycins and AC/AP agents from database inception through August 2021. The 29 studies identified examined warfarin (n = 17), direct oral anticoagulants (DOACs) (n = 8), and antiplatelet agents (n = 4) combined with rifampin (n = 28) or rifabutin (n = 1). Eleven studies were case reports or small case series; 14 reported on pharmacokinetic or laboratory markers in healthy volunteers. Rifampin-warfarin combinations led to reductions in warfarin area under the curve (AUC) of 15%–74%, with variability by warfarin isomer and study. Warfarin dose increases of up to 3–5 times prerifampin doses were required to maintain coagulation parameters in the therapeutic range. DOAC AUCs were decreased by 20%–67%, with variability by individual agent and with rifampin versus rifabutin. The active metabolite of clopidogrel increased substantially with rifampin coadministration, whereas prasugrel was largely unaffected and ticagrelor saw decreases. Our review suggests most combinations of AC/AP agents and rifampin are problematic. Further studies are required to determine whether rifabutin or rifapentine could be safe alternatives for coadministration with AC/AP drugs. 相似文献
39.
Tsvetelina Velikova 《World Journal of Immunology》2022,12(2):9-14
To control the pandemic, efficient vaccines must be applied to the population, including patients with autoimmune diseases. Therefore, one can expect that coronavirus disease 2019 (COVID-19) vaccines may influence the underlying autoimmune processes in these patients. Additionally, it is essential to understand whether COVID-19 vaccines would be effective, safe, and provide long-lasting immunological protection and memory. However, the currently available and approved COVID-19 vaccines turned out to be safe, effective, and reliable in patients with autoimmune inflammatory and rheumatic diseases. Furthermore, most patients said they felt safer after getting vaccinations for COVID-19 and reported enhanced overall quality of life and psychological wellbeing. In general, the COVID-19 vaccines have been highly tolerated by autoimmune patients. Such findings might comfort patients who are reluctant to use COVID-19 vaccines and assist doctors in guiding their patients into receiving vaccinations more easily and quickly. 相似文献
40.
《Saudi Pharmaceutical Journal》2022,30(6):655-668
Most vaccines approved by regulatory bodies are administered via intramuscular or subcutaneous injections and have shortcomings, such as the risk of needle-associated blood infections, pain and swelling at the injection site. Orally administered vaccines are of interest, as they elicit both systemic and mucosal immunities, in which mucosal immunity would neutralize the mucosa invading pathogen before the onset of an infection. Hence, oral vaccination can eliminate the injection associated adverse effects and enhance the person's compliance. Conventional approaches to manufacturing oral vaccines, such as coacervation, spray drying, and membrane emulsification, tend to alter the structural proteins in vaccines that result from high temperature, organic and toxic solvents during production. Electrohydrodynamic processes, specifically electrospraying, could solve these challenges, as it also modulates antigen release and has a high loading efficiency. This review will highlight the mucosal immunity and biological basis of the gastrointestinal immune system, different oral vaccine delivery approaches, and the application of electrospraying in vaccines development. 相似文献